Please login to the form below
HIV
This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.
Pfizer launches early study of COVID-19 antiviral therapeutic
Previously, protease inhibitors have been effective for the treatment of other viral pathogens, including HIV and hepatitis C virus, when administered alone and in combination with additional antivirals.
Latest news
-
Q&A: Avril Lee
outcomes and lives in HIV and cancer.
-
Novavax COVID-19 vaccine found to be 86% effective against UK variant
adults, while a second cohort evaluated the vaccine in around 240 medically stable, HIV-positive volunteers. ... Among HIV-negative participants, the efficacy of NVX-CoV2373 was found to be 55.4%, with complete analysis showing that vaccine-induced
-
Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
It also holds the promise of applying lessons learned to help develop potentially curative options for other debilitating diseases affecting low-income populations, such as HIV,” he added.
-
FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
its other investigational candidates for Zika, RSV and HIV.
-
Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4
business. This included HIV products sales, which were down 7% in the fourth quarter to $4.3bn – although full-year sales were up 3% to $16.9bn in 2020.
More from news
Approximately 91 fully matching, plus 547 partially matching documents found.
Latest Intelligence
-
Awards or not, what really matters is... can you make it mean something?
This was big news, a landmark moment for the HIV community: undetectable = untransmittable. ... Helping prevent further HIV transmission and protect those living with HIV to live longer, healthier lives.
-
As COVID-19 takes over the world, biopharma fights back
A combination HIV treatment: AbbVie’s Kaletra. In an unprecedented move, AbbVie has suspended its patents on its combination HIV drug Kaletra, after it was identified as having potential against ... 19. Kaletra combines two antivirals, lopinavir and
-
Tackling antimicrobial resistance on multiple fronts
We already have effective mechanisms that fund access to vaccines, TB, HIV and malaria.
-
Keeping up the fight against HIV and using the lessons to tackle other threats
The strategy echoes its HIV heritage and continuing practice of working closely with patient groups in all aspects of drug development. ... He added: “We have medicines that provide good treatments for a broad group of patients, particularly those
-
The mission matters
The success of vaccines, antibiotics, HIV treatments and many other therapies is evidence of how society has benefited from the deal.
More from intelligence
Approximately 4 fully matching, plus 53 partially matching documents found.
Latest appointments
-
McCann Health North America appoints Jim Joseph as president
Joseph also has expertise in a number of therapeutics areas, including cardiovascular, upper respiratory, HIV, dermatology and more.
-
Porter Novelli adds Amber Tovey to London health team
In her new role at Porter Novelli, Tovey will work across a global pharmaceutical client portfolio that includes neurology, rare diseases and HIV.
-
Aelix Therapeutics appoints Dr Thomas Hecht
its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the
-
emotive boosts its client services team
Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.
-
GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet
GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down from the HIV-focused firm at the end of March. ... We have delivered scientific innovation, while listening and better understanding the
More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Fear or encouragement, which is best to drive behaviour change?
Thinking back to the HIV campaigns of the 1980s, which focused on fear to try to prevent the spread of HIV, they may have had short-term success in raising awareness ... a lot of outdated knowledge and opinion about HIV amongst the general population,
-
#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
However, once these trials are divided up into specific diseases the underrepresentation becomes clearer, especially in the fields of cardiovascular diseases, hepatitis, HIV, chronic kidney disease and digestive diseases.
-
NORD Rare Diseases Breakthrough Summit
One perspective presented during this session was how the treatment of HIV has been ‘Globalised’ and what lessons can be learned from this.
-
Our latest additions
She has led the launches of new HIV treatments in the EU, developing media strategies and approaches ahead of regulatory milestones and data announcements at multiple congresses.
-
DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
More likely to be living with HIV. More likely to be homeless or insecurely housed. ... Undiagnosed HIV infection” and “Heart disease risk” - as well as talk around key evidence gaps, donor eligibility and lifestyle factors including diet, alcohol
More from PMHub
Approximately 4 fully matching, plus 32 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- GSK discontinues two feladilimab trials in head and neck cancer
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- Live Webinar: Advancing Human Health Through Precise Measures of Movement, Cognition & Biometrics
- Live Webinar: How to Simplify Genetics & Raise Awareness Around Orphan Diseases
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
PMHub
90TEN
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
